Evan Loh

@EvanLohMD

Physician, father, and drug developer focused on bringing new antibiotics to physicians and patients

Vrijeme pridruživanja: travanj 2016.

Tweetovi

Blokirali ste korisnika/cu @EvanLohMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EvanLohMD

  1. 19. pro 2019.

    We are grateful for ’s commitment to addressing the global threat of antimicrobial resistance and their investment in public-private partnerships such as the one announced this week with my company

    Poništi
  2. 18. pro 2019.

    Excited to share today’s important announcement.

    Poništi
  3. 21. stu 2019.

    Proud to have partnered with the members of on the development of the principles announced yesterday

    Poništi
  4. 7. stu 2019.

    Thank you and for your thoughtful Op-Ed placing the spotlight on the challenge of antimicrobial resistance and for your commitment to changing the system so we can resolve this growing public health crisis.

    Poništi
  5. proslijedio/la je Tweet

    ., Chief Executive Officer of and Chairman of the AWG, comments on AWG's presence at . For more information on AWG member company presentations and access to specific abstracts, please visit:

    Poništi
  6. 27. kol 2019.

    Excited to lend expertise and support to to help educate the public about antimicrobial resistance and advocate for policies that help fight superbugs. Learn more

    Poništi
  7. 25. lip 2019.

    Honored to have the opportunity to lead through the next phase of growth as we work to continue the successful launch and commercialization of NUZYRA in the U.S. and establish Paratek as the leader in the anti-infective space.

    Poništi
  8. 6. lip 2019.

    Great news! This week, the DISARM Act of 2019 was introduced on the Hill to encourage development of new therapies and directly address the challenge of in hospitals. All of us support this bill.

    Poništi
  9. proslijedio/la je Tweet

    Key Officials, incl. Dr. Ed Cox, Director, Office of Antimicrobial Products, put out a call for renewed focus on development & the need for add'l initiatives & incentives to bring new life-saving anti-infectives to market: via

    Poništi
  10. 7. velj 2019.

    Thanks to and for their story on this important topic. Greater policy support for antimicrobial development is essential to ensure a future with adequate treatment options.

    Poništi
  11. 17. sij 2019.

    Honored to be elected Chair of to advance AWG's mission to improve the regulatory, investment, and commercial environment for emerging infectious disease companies.

    Poništi
  12. 15. lis 2018.

    Thanks to for a terrific story in about the future of antibiotics. Delighted to have been a part of it.

    Poništi
  13. 10. lis 2018.

    Proud to have contributed to the -News discussion @IDWeek2018 about the need for changes to the reimbursement environment. A unified effort is critical to ensuring the continued investment in novel antibiotics.

    Poništi
  14. 8. kol 2018.

    Proud to share the positive outcome of today’s Advisory Committee meeting!

    Poništi
  15. 3. kol 2018.

    Sharing my views on building a fully integrated biopharmaceutical company via CEO Corner

    Poništi
  16. 9. srp 2018.
    Prikaži ovu nit
    Poništi
  17. 9. srp 2018.

    The proposed REVAMP bill is an important policy to incentivize antimicrobial development. Improved pull incentives are greatly needed in order to drive the kind of innovation necessary to combat .

    Prikaži ovu nit
    Poništi
  18. 26. lip 2018.

    Special thanks to Rep. Roger Marshall () for organizing the meeting and to all the caucus members in attendance. We appreciate your time and the leadership you have shown in the fight against

    Prikaži ovu nit
    Poništi
  19. 26. lip 2018.

    Today members of the Executive Committee had the opportunity to meet with the GOP Doctors Caucus to address the current challenges in developing new tools to fight and discuss policies that could reinvigorate investment in the antibiotics development pipeline.

    Prikaži ovu nit
    Poništi
  20. 6. lip 2018.

    Thank you for having me on the “Value of Addressing AMR” panel today to discuss promising incentive models for novel development.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·